Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
The global market for Eye Drops (Artificial Tear) was estimated to be worth US$ 3151 million in 2023 and is forecast to a readjusted size of US$ 4090.1 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sj枚gren's syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eye Drops (Artificial Tear), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Eye Drops (Artificial Tear) by region & country, by Type, and by Application.
The Eye Drops (Artificial Tear) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops (Artificial Tear).
麻豆原创 Segmentation
By Company
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type:
Allergy Eye Care
Standard Eye Care
Segment by Application
Pharmacy
Internet
Grocery
Optical Chains
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Eye Drops (Artificial Tear) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Eye Drops (Artificial Tear) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Eye Drops (Artificial Tear) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Eye Drops (Artificial Tear) Product Introduction
1.2 Global Eye Drops (Artificial Tear) 麻豆原创 Size Forecast
1.2.1 Global Eye Drops (Artificial Tear) Sales Value (2019-2030)
1.2.2 Global Eye Drops (Artificial Tear) Sales Volume (2019-2030)
1.2.3 Global Eye Drops (Artificial Tear) Sales Price (2019-2030)
1.3 Eye Drops (Artificial Tear) 麻豆原创 Trends & Drivers
1.3.1 Eye Drops (Artificial Tear) Industry Trends
1.3.2 Eye Drops (Artificial Tear) 麻豆原创 Drivers & Opportunity
1.3.3 Eye Drops (Artificial Tear) 麻豆原创 Challenges
1.3.4 Eye Drops (Artificial Tear) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Eye Drops (Artificial Tear) Players Revenue Ranking (2023)
2.2 Global Eye Drops (Artificial Tear) Revenue by Company (2019-2024)
2.3 Global Eye Drops (Artificial Tear) Players Sales Volume Ranking (2023)
2.4 Global Eye Drops (Artificial Tear) Sales Volume by Company Players (2019-2024)
2.5 Global Eye Drops (Artificial Tear) Average Price by Company (2019-2024)
2.6 Key Manufacturers Eye Drops (Artificial Tear) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Eye Drops (Artificial Tear) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Eye Drops (Artificial Tear)
2.9 Eye Drops (Artificial Tear) 麻豆原创 Competitive Analysis
2.9.1 Eye Drops (Artificial Tear) 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Eye Drops (Artificial Tear) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drops (Artificial Tear) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Allergy Eye Care
3.1.2 Standard Eye Care
3.2 Global Eye Drops (Artificial Tear) Sales Value by Type
3.2.1 Global Eye Drops (Artificial Tear) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Eye Drops (Artificial Tear) Sales Value, by Type (2019-2030)
3.2.3 Global Eye Drops (Artificial Tear) Sales Value, by Type (%) (2019-2030)
3.3 Global Eye Drops (Artificial Tear) Sales Volume by Type
3.3.1 Global Eye Drops (Artificial Tear) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Eye Drops (Artificial Tear) Sales Volume, by Type (2019-2030)
3.3.3 Global Eye Drops (Artificial Tear) Sales Volume, by Type (%) (2019-2030)
3.4 Global Eye Drops (Artificial Tear) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy
4.1.2 Internet
4.1.3 Grocery
4.1.4 Optical Chains
4.2 Global Eye Drops (Artificial Tear) Sales Value by Application
4.2.1 Global Eye Drops (Artificial Tear) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Eye Drops (Artificial Tear) Sales Value, by Application (2019-2030)
4.2.3 Global Eye Drops (Artificial Tear) Sales Value, by Application (%) (2019-2030)
4.3 Global Eye Drops (Artificial Tear) Sales Volume by Application
4.3.1 Global Eye Drops (Artificial Tear) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Eye Drops (Artificial Tear) Sales Volume, by Application (2019-2030)
4.3.3 Global Eye Drops (Artificial Tear) Sales Volume, by Application (%) (2019-2030)
4.4 Global Eye Drops (Artificial Tear) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Eye Drops (Artificial Tear) Sales Value by Region
5.1.1 Global Eye Drops (Artificial Tear) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Eye Drops (Artificial Tear) Sales Value by Region (2019-2024)
5.1.3 Global Eye Drops (Artificial Tear) Sales Value by Region (2025-2030)
5.1.4 Global Eye Drops (Artificial Tear) Sales Value by Region (%), (2019-2030)
5.2 Global Eye Drops (Artificial Tear) Sales Volume by Region
5.2.1 Global Eye Drops (Artificial Tear) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Eye Drops (Artificial Tear) Sales Volume by Region (2019-2024)
5.2.3 Global Eye Drops (Artificial Tear) Sales Volume by Region (2025-2030)
5.2.4 Global Eye Drops (Artificial Tear) Sales Volume by Region (%), (2019-2030)
5.3 Global Eye Drops (Artificial Tear) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Eye Drops (Artificial Tear) Sales Value, 2019-2030
5.4.2 North America Eye Drops (Artificial Tear) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Eye Drops (Artificial Tear) Sales Value, 2019-2030
5.5.2 Europe Eye Drops (Artificial Tear) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Eye Drops (Artificial Tear) Sales Value, 2019-2030
5.6.2 Asia Pacific Eye Drops (Artificial Tear) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Eye Drops (Artificial Tear) Sales Value, 2019-2030
5.7.2 South America Eye Drops (Artificial Tear) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Eye Drops (Artificial Tear) Sales Value, 2019-2030
5.8.2 Middle East & Africa Eye Drops (Artificial Tear) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Eye Drops (Artificial Tear) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Eye Drops (Artificial Tear) Sales Value
6.2.1 Key Countries/Regions Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Eye Drops (Artificial Tear) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.3.2 United States Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.4.2 Europe Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.5.2 China Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.6.2 Japan Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.7.2 South Korea Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.8.2 Southeast Asia Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Eye Drops (Artificial Tear) Sales Value, 2019-2030
6.9.2 India Eye Drops (Artificial Tear) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Eye Drops (Artificial Tear) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Information
7.1.2 Allergan Introduction and Business Overview
7.1.3 Allergan Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allergan Eye Drops (Artificial Tear) Product Offerings
7.1.5 Allergan Recent Development
7.2 Alcon
7.2.1 Alcon Company Information
7.2.2 Alcon Introduction and Business Overview
7.2.3 Alcon Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alcon Eye Drops (Artificial Tear) Product Offerings
7.2.5 Alcon Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Introduction and Business Overview
7.3.3 Novartis Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis Eye Drops (Artificial Tear) Product Offerings
7.3.5 Novartis Recent Development
7.4 Santen Pharma
7.4.1 Santen Pharma Company Information
7.4.2 Santen Pharma Introduction and Business Overview
7.4.3 Santen Pharma Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Santen Pharma Eye Drops (Artificial Tear) Product Offerings
7.4.5 Santen Pharma Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Introduction and Business Overview
7.5.3 Johnson & Johnson Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Johnson & Johnson Eye Drops (Artificial Tear) Product Offerings
7.5.5 Johnson & Johnson Recent Development
7.6 Bausch & Lomb
7.6.1 Bausch & Lomb Company Information
7.6.2 Bausch & Lomb Introduction and Business Overview
7.6.3 Bausch & Lomb Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bausch & Lomb Eye Drops (Artificial Tear) Product Offerings
7.6.5 Bausch & Lomb Recent Development
7.7 Thea pharmaceuticals
7.7.1 Thea pharmaceuticals Company Information
7.7.2 Thea pharmaceuticals Introduction and Business Overview
7.7.3 Thea pharmaceuticals Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Thea pharmaceuticals Eye Drops (Artificial Tear) Product Offerings
7.7.5 Thea pharmaceuticals Recent Development
7.8 URSAPHARM
7.8.1 URSAPHARM Company Information
7.8.2 URSAPHARM Introduction and Business Overview
7.8.3 URSAPHARM Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 URSAPHARM Eye Drops (Artificial Tear) Product Offerings
7.8.5 URSAPHARM Recent Development
7.9 SIMILASAN
7.9.1 SIMILASAN Company Information
7.9.2 SIMILASAN Introduction and Business Overview
7.9.3 SIMILASAN Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 SIMILASAN Eye Drops (Artificial Tear) Product Offerings
7.9.5 SIMILASAN Recent Development
7.10 Akorn
7.10.1 Akorn Company Information
7.10.2 Akorn Introduction and Business Overview
7.10.3 Akorn Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Akorn Eye Drops (Artificial Tear) Product Offerings
7.10.5 Akorn Recent Development
7.11 United Laboratories
7.11.1 United Laboratories Company Information
7.11.2 United Laboratories Introduction and Business Overview
7.11.3 United Laboratories Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 United Laboratories Eye Drops (Artificial Tear) Product Offerings
7.11.5 United Laboratories Recent Development
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Company Information
7.12.2 Sun Pharmaceutical Introduction and Business Overview
7.12.3 Sun Pharmaceutical Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sun Pharmaceutical Eye Drops (Artificial Tear) Product Offerings
7.12.5 Sun Pharmaceutical Recent Development
7.13 Jianfeng Group
7.13.1 Jianfeng Group Company Information
7.13.2 Jianfeng Group Introduction and Business Overview
7.13.3 Jianfeng Group Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jianfeng Group Eye Drops (Artificial Tear) Product Offerings
7.13.5 Jianfeng Group Recent Development
8 Industry Chain Analysis
8.1 Eye Drops (Artificial Tear) Industrial Chain
8.2 Eye Drops (Artificial Tear) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Eye Drops (Artificial Tear) Sales Model
8.5.2 Sales Channel
8.5.3 Eye Drops (Artificial Tear) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
听
听
*If Applicable.